JOHNSON & JOHNSON JNJ → DePuy Synthes (Orthopaedics business)
Distributionpending
| Parent | JOHNSON & JOHNSON JNJ |
|---|---|
| Spinco | DePuy Synthes (Orthopaedics business) |
| Status | Announced |
| Structure | Structure undecided The parent has announced a separation without committing to a spin-off; a sale or an offering may be live alternatives. |
| Focus | Focus unclassified Deliberately unjudged. The industry codes and the businesses disagree, and this site does not resolve that by guessing. |
| Ratio | not declared |
| Checked against EDGAR | 2026-08-21 |
Catalyst clock
- 2025-10-14Separation announced
- —Form 10 filed
- —Form 10 last amended
- —Form 10 effective
- —Record date
- —When-issued trading opens
- —Distribution
- —First standalone earnings
- —Index inclusion announced
Filings
Every fact on this page comes from one of these.
- 8-Kfiled 2025-10-14 · 0000200406-25-000201Item 8.01 announcing the intent to separate the Orthopaedics business; Ex-99.3 is the press release, dated October 14, 2025
- 10-Qfiled 2026-07-23 · 0000200406-26-000153States the company continues to explore multiple paths to effect the separation, targeting completion within 18 to 24 months of the announcement
Notes
The announcement date is 2025-10-14, taken from the 8-K and the press release itself — competitor calendars carry 2025-10-13, which no filing supports. Structure remains undetermined nine months on: the July 2026 10-Q still says Johnson & Johnson is exploring multiple paths, and its risk factors list the structure of the transaction as an open item. The separated business would operate as DePuy Synthes. Conditions include works council consultations in Europe, final board approval and regulatory clearances.